Rapamycin circumvents anti PD-1 therapy resistance in colorectal cancer by reducing PD-L1 expression and optimizing the tumor microenvironment

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China-Guangdong Joint Fund
  • Guilin Medical University (2024SRP104)
  • Natural Science Foundation of Guangdong Province
  • Basic and Applied Basic Research Foundation of Guangdong Province (2024A03J0189)
  • Basic and Applied Basic Research Foundation of Guangdong Province (2024A06J0188)
  • Basic and Applied Basic Research Foundation of Guangdong Province (2024A03J0188)

This publication has 51 references indexed in Scilit: